CAS: 1269026-22-3; Ethyl 6-Bromo-3-Hydroxy-5-Methylpyrazine-2-Carboxylate

该化合物是一种含有氢氧基和酯功能组的溴化丙衍生物,使其成为有机合成的多用途中间体,其结构特征,包括电子脱色溴替代成分和反应式氢氧化物组,有利于进一步衍生,特别是在制药和农用化学应用中.该化合物在标准条件下的稳定性和明确界定的再活性剖面图增强了其在交叉相交反应和异环对环成鱼改造中的效用.其晶体形式确保了始终的纯性,而乙烷混合物提供了有机溶剂的溶性,简化了下游加工.该化合物对于研究人员开发新型的丙苯基生物活性分子尤其具有价值.

结构式图片

相似化合物

21874-61-3 141872-22-2 859064-08-7

欧盟法规

C&L通报

上下游产品

3-羟基-5-甲基吡嗪-2-羧酸乙酯 Ethyl 3-Hydroxy-5-Methylpyrazine-2-Carboxylate 141872-22-2

合成工艺路线路线简述

  • 合成目标产物 Ethyl 6-Bromo-3-Hydroxy-5-Methylpyrazine-2-Carboxylate 主要起始原料 Ethyl 3-Hydroxy-5-Methylpyrazine-2-Carboxylate
  • (文献来源)合成步骤主要原料 Ethyl 3-Hydroxy-5-Methylpyrazine-2-Carboxylate
📜酮基丙二酸二乙酯置于n-溴代丁二酰亚胺(Nbs)体系中,用 乙醇,N,N-二甲基甲酰胺 用作溶剂,化学反应 23.0H,反应生成6-溴-5-甲基-3-氧代-3,4-二氢吡嗪-2-羧酸乙酯
参考文献: Pyrrolopyrazole Spiro Compound[fr] Composé Spiro De Pyrrolopyrazole[zh] 吡咯并吡唑螺环化合物
标题: Pyrrolopyrazole Spiro Compound[fr] Composé Spiro De Pyrrolopyrazole[zh] 吡咯并吡唑螺环化合物
摘要:公开了一类吡咯并吡唑螺环化合物,及其在制备治疗相关疾病的药物中的应用,具体涉及式(I')化合物,其立体异构体及其药学上可接受的盐.

海关参考信息

专利信息


专利号:US-2024239799-A1
优先权日:2021-04-02
标 题:(s)-1-(5-((pyridin-3-yl)thio)pyrazin-2-yl)-4'h,6'h-spiro[piperidine-4,5'-pyrrolo [1,2-b]pyrazol]-4'-amine derivatives and similar compounds as shp2 inhibitors for the treatment of e.g. cancer
发明人:DI FABIO ROMANO; MONTALBETTI CHRISTIAN; PETROCCHI ALESSIA; GRILLO ALESSANDRO; RANDAZZO PIETRO; ROSSETTI ILARIA; CIAMMAICHELLA ALINA
权利人:C N C C S S C A R L COLLEZIONE NAZ DEI COMPOSTI CHIMICI E CENTRO SCREENING; IRBM S P A
摘要:The present invention relates to compounds of formula (I). The compounds of the formula (I) are e.g. (S)-1-(5-((pyridin-3-yl)thio) pyrazin-2-yl)-41H,6′H-spiro[piperidine-4,5′-pyrrolo[1,2-b]pyrazol]-41-amine derivatives and similar compounds. The present invention also relates to the compounds of formula (I) for use as Src homology phosphotyrosine phosphatase 2 (SHP2) inhibitors in methods of treatment of e.g. cancer, cardiovascular diseases, immunological disorders, autoimmune disorders, fibrosis, ocular disorders, systemic lupus erythematosus, diabetes, neutropenia, and combinations thereof. The present invention also relates to pharmaceutical compositions containing said compounds and to their methods of synthesis.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知